Mediware Releases HCLL(TM) Donor for FDA 510(K) Review

LENEXA, Kan., Feb. 24 /PRNewswire-FirstCall/ -- Mediware Information Systems, Inc. , a known leader in healthcare delivery and patient safety software management solutions, announced today that it has submitted its next generation donor management system, HCLL(TM) Donor, to the US Food and Drug Administration (FDA) for 510(k) clearance.

HCLL(TM) Donor, when available, will continue the company’s leading position in the hospital donor services market by providing the following management features and support including:

 * A common look and feel with the advanced HCLL(TM) Transfusion system, providing a rich graphical “heads up” display of real-time safety- critical and operational information. * Real-time integration with the advanced HCLL(TM) Transfusion system, seamlessly tying together the donor and transfusion service centers within a healthcare enterprise. * A common technology architecture with the advanced HCLL(TM) Transfusion system, providing an N-Tier application that is deployable in Client/Server or Thin-Client platform configurations. * Full support of Industry bar code standards including ISBT 128 and CODABAR. 

“The submission of HCLL(TM) Donor for 510(k) clearance is the culmination of several years of market research, product development and field testing, " said Frank Poggio, vice-president and general manager of Mediware’s Blood Bank Division. “We have designed HCLL Donor to build upon and extend the foundation of the advanced HCLL(TM) Transfusion system. We fully expect HCLL(TM) Donor to have the same substantial positive impact on customer operations as our advanced HCLL(TM) Transfusion system,” Mr. Poggio said.

About Mediware

Mediware provides clinical information systems for hospitals and integrated healthcare delivery systems. Its products include HEMOCARE LifeLine(TM), Hemocare(R), LifeLine(R) and LifeTrak(R) (blood bank), WORx(R), MediMAR(TM), and MediCOE(TM) (medication management), Surgiware(TM) and Perioperative Solutions(TM) (operating room), as well as the JAC Stock Control System (pharmacy) in the United Kingdom. Mediware has over 1,100 systems installed in the U.S., Canada, the U.K., and elsewhere.

Certain statements in this press release may constitute “forward-looking’’ statements within the meaning of the Private Securities Litigation Reform Act of 1995, as the same may be amended from time to time (the “Act”) and in releases made by the SEC from time to time. Such forward-looking statements are not based on historical facts and involve known and unknown risks, uncertainties and other factors disclosed in the Company’s Annual Report on Form 10-K for the year ended June 30, 2004, which may cause the actual results of the Company to be materially different from any future results expressed or implied by such forward-looking statements. The Company disclaims any obligation to update its forward-looking statements.

CONTACT: George Barry 913/307-1000 Thomas Redington 203/222-7399 212/926-1733

Mediware Information Systems, Inc.

CONTACT: George Barry of Mediware Information Systems, Inc.,+1-913-307-1000; Thomas Redington, +1-203-222-7399, or +1-212-926-1733, forMediware Information Systems, Inc.